Immunofluorescence assays revealed alterations in RHBDD1 levels impacting the expression of β-catenin within the nucleus, suggesting a potential role of RHBDD1 in activating the Wnt/β-catenin signaling pathway, thereby facilitating invasion and migration of ESCC cells. Here, RHBDD1 is linked to esophageal squamous cell carcinoma.